Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.

Saved in:
Bibliographic Details
Title: Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.
Authors: Pongor LS; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; HCEMM Cancer Genomics and Epigenetics Research Group, Szeged, Hungary., Schultz CW; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Rinaldi L; Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Wangsa D; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Redon CE; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Takahashi N; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Fialkoff G; School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel., Desai P; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Zhang Y; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Burkett S; Molecular Cytogenetic Core Facility, Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland., Hermoni N; School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.; School of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Vilk N; School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.; School of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Gutin J; School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel., Gergely R; Department of Biochemistry and Molecular Pharmacology, NYU, New York, New York.; Laura and Isaac Perlmutter NYU Cancer Center, New York, New York.; Howard Hughes Medical Institute, New York University Grossman School of Medicine, New York, New York., Zhao Y; Bioinformatics and Computational Science Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Nichols S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Vilimas R; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Sciuto L; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Graham C; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Caravaca JM; Bioinformatics and Computational Science Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Turan S; Bioinformatics and Computational Science Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Tsai-Wei S; Howard Hughes Medical Institute, New York University Grossman School of Medicine, New York, New York., Rajapakse VN; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Kumar R; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Upadhyay D; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Kumar S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Kim YS; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Roper N; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Tran B; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Hewitt SM; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Kleiner DE; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Aladjem MI; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Friedman N; School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.; School of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Hager GL; Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Pommier Y; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Ried T; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Thomas A; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Source: Cancer discovery [Cancer Discov] 2023 Apr 03; Vol. 13 (4), pp. 928-949.
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-22-0796